KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib (Q21563446)

From Wikidata
Jump to navigation Jump to search
scientific article
  • KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
edit
Language Label Description Also known as
English
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
scientific article
  • KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib

Statements

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib (English)
January 2005
0 references
2
0 references
1
0 references
e17
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit